Trial Section
Home / Trial Section / Clinical Trial| Indication | Department | Study Title | Study Phase | Investigator | Contact Person | Status |
|---|---|---|---|---|---|---|
| Head and Neck Cancer | Hematology and Oncology | BelieveIT-201: A Randomized, Phase 2, Open-label Trial of TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) | Phase II | Hui-Ching Wang | 俞念廷 | On-going |
| Atherosclerotic Cardiovascular Disease | Cardiology | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) who have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event – ACCLAIM-Lp(a) | Phase III | Tsung-Hsien Lin | 江書瑜 | On-going |
| Hepatitis | Hepatobiliary and Pancreatic Medicine | A Long-Term Follow-up Study for Subjects with Chronic Hepatitis B Previously Treated with Imdusiran (AB-729) | -- | Wan-Long Chuang | 莊心婷 | On-going |
| Sjogren's Syndrome | Rheumatology, Immunology and Allergology | A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjogren’s Syndrome With Moderate-to-severe Systemic Disease Activity | Phase III | Cheng-Chin Wu | 張銘真 | On-going |
| Psoriasis | Dermatology | A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis | Phase III | Cheng-Che Lan | 郭靜芳 | On-going |
| 慢性腎臟病 | Cardiology | A Phase IIb, Multicentre, Randomised, Double-Blind, Dose-finding Study to Evaluate the Efficacy, Safety and Tolerability of Balcinrenone in Combination with Dapagliflozin Compared with Dapagliflozin in Patients with Chronic Kidney Disease and Albuminuria | Phase II | Tsung-Hsien Lin | 江書瑜 | On-going |
| Solid Tumor | Colorectal Surgery | A Phase 1 First-in Human, Multi-Center, Open Label Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics and RP2D of Livmoniplimab(ABBV-151) as a Single Agent and in Combination with Budigalimab(ABBV-181) in Subjects with Locally Advanced or Metastatic Solid Tumors | Phase I | WANG,JAW-YUAN | 江婕綺 | On-going |
| Myeloid Leukemia | Hematology and Oncology | A Phase 1b Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced Cancer | Phase I | Hui-Hua Hsiao | 梁素綾 | On-going |
| Plastic Surgery | A Phase 3, Multicenter, Randomized, Placebo-Controlled Study of AGN-151586 for the Treatment of Moderate to Severe Glabellar Lines | Phase III | SHU-HUNG HUANG | 鄭琪云 | On-going | |
| Infectious Diseases | A Clinical Evaluation POCKIT™ Central SARS-CoV-2 (2.0) Premix Reagent in Detect of SARS-CoV-2 | Class III | TSAI,JIH-JIN | 徐妙禎 | On-going |
← Please slide to the left for more information